Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-005394
Filing Date
2022-05-17
Accepted
2022-05-17 17:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 30032
2 filename2.txt TEXT-EXTRACT 4975
  Complete submission text file 0000000000-22-005394.txt   46999
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filed for) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)